D-0050-2017 Class II Terminated
FDA drug recall D-0050-2017 was initiated by Pharmedium Services, LLC on Jul 17, 2015 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes. The recall status is terminated (terminated Jun 23, 2017). Affected quantity: 1916 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 19, 2016
- Initiation Date
- Jul 17, 2015
- Termination Date
- Jun 23, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1916 syringes
Product Description
HYDROmorphone HCl, 0.2 mg per mL, (0.4 mg per 2 mL), in 0.9% Sodium Chloride, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3162.
Reason for Recall
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Distribution Pattern
Nationwide
Code Information
Lot Numbers: 151200003M, 151260128M, 151300005M, 151310094M, 151320134M, 151320143M, 151340107M, 151370002M, 151390005M, 151390142M, 151400005M, 151400095M, 151400136M, 151470008M, 151510002M, 151520080M, 151880214M, 151890257M, Exp between 07/15/15-10/12/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0050-2017
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026